GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vijaya Diagnostic Centre VIJAYA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,478.30

+0.66%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Vijaya Diagnostic Centre

Its shares trade on NSE under the ticker VIJAYA.NS. It has been listed since 14 September 2021. In the fiscal year to 31 March 2026, it reported revenue of ₹8.14bn and net income of ₹1.73bn. At that date it held total assets of ₹15.07bn and shareholders' equity of ₹9.57bn.

Vijaya Diagnostic Centre Ltd. engages in the provision of diagnostic services. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-09-14. The firm is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The firm operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The firm also offers a range of health and wellness packages to its customers as per their requirements. The company operates approximately 121 diagnostic centers and 17 reference laboratories in 20 cities spread across India.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
14 Sept 2021
Employees
1,996

Leadership

Pay as last reported

  • Dr. Sura ReddyExecutive Chairman of the Board, Founder₹20.0m
  • Ms. Sura ReddyChief Executive Officer, Managing Director, Executive Director₹27.5m
  • Mr. Ankit ShahChief Financial Officer
  • Mr. Venkata VegesnaChief Operating Officer
  • Mr. Sai PrasadChief Technology Officer
  • Mr. Hansraj RajputCompany Secretary & Compliance Officer
  • Mr. Sunil KondapallyExecutive Director₹10.0m
  • Mrs. Sura ReddyNon-Executive Non-Independent Director
  • Dr. Manjula AnaganiNon-Executive Independent Director₹1.2m
  • Dr. Sasikala KolaAdditional Non-Executive Independent Director
  • Mr. Chavali MurthyNon-Executive Independent Director₹1.2m
  • Dr. Duvvur ReddyNon-Executive Independent Director₹1.2m

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
53
Environment
31
Social
60
Governance
67
Women in the workforce
40.81831%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Vijaya Diagnostic Centre Ltd operates 121 diagnostic centers across 20 Indian cities, providing extensive coverage.
  • The company offers a wide range of diagnostic services including high-end molecular tests and advanced imaging.
  • With 1,996 employees, Vijaya provides comprehensive healthcare services through its 17 reference laboratories.

Weaknesses

  • The company's operations are limited to India, with no international presence mentioned in the facts.
  • Vijaya's diagnostic centers are concentrated in 20 cities, potentially missing rural and underserved areas.
  • The firm's reliance on a single sector, Health Care, may limit diversification opportunities.

Opportunities

  • Expanding into rural areas could tap into underserved populations across India.
  • Increasing demand for high-end molecular diagnostic tests presents growth potential.
  • The company can leverage its 17 reference laboratories to enhance service quality and reach.

Threats

  • Competition from other diagnostic service providers in India may intensify.
  • Economic downturns could reduce healthcare spending by individuals and businesses.
  • Regulatory changes in the Indian healthcare sector might impact operations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.